A leading pharmaceutical company was encountering issues when attempting to scale up a new immediate-release tablet formulation. During early trials, the formulation scientists encountered several compression challenges such as capping, lamination and inconsistent hardnesses, which prevented them from achieving the target tablet quality.
Their in-house resources were already stretched, and limited quantities of active material meant traditional large-scale trails were impractical. The client required quantitative, small-sample data to understand the root causes and guide formulation adjustments before proceeding further.